TrianglePUBLICATIONS · 38072625
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Apr 1
- First author
- Wang M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wang M
- type
- Author
- name
- Siddiqi T
- type
- Author
- name
- Gordon LI
- type
- Author
- name
- Kamdar M
- type
- Author
- name
- Lunning M
- type
- Author
- name
- Hirayama AV
- type
- Author
- name
- Abramson JS
- type
- Author
- name
- Arnason J
- type
- Author
- name
- Ghosh N
- type
- Author
- name
- Mehta A
- type
- Author
- name
- Andreadis C
- type
- Author
- name
- Solomon SR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wang M
- type
- Author
- name
- Siddiqi T
- type
- Author
- name
- Gordon LI
- type
- Author
- name
- Kamdar M
- type
- Author
- name
- Lunning M
- type
- Author
- name
- Hirayama AV
- type
- Author
- name
- Abramson JS
- type
- Author
- name
- Arnason J
- type
- Author
- name
- Ghosh N
- type
- Author
- name
- Mehta A
- type
- Author
- name
- Andreadis C
- type
- Author
- name
- Solomon SR
- type
- Author
- bibliography ids
- nci-bib-a9a08d928595b6e108fc246a
- book metadata
- content sha256
- a926722c7d2f2944913f317fd3dda3baabdf3f3b87e1f5e9de12ac530ba33a37
- document type
- citation
- dois
- 10.1200/JCO.23.02214
- electronic publication date
- display
- 2023 Dec 10
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38072625
- immutable id
- pubmed:38072625@a926722c7d2f2944913f317fd3dda3baabdf3f3b87e1f5e9de12ac530ba33a37
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1146-1157
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38072625
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- b955ebd425a8a2f1b91e53eef83851465a894900c98f9a6211c6d8e7f35452b0
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Apr 1
- precision
- day
- year
- 2024
- publication types
- Clinical Trial, Phase I
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.
Preserved source evidence · Not medical advice